00006-4119 GARDASIL 9

Product NDC:

00006-4119

Brand Name:

GARDASIL 9

Generic Name:

Human Papillomavirus 9-valent Vaccine, Recombinant

Dosage Form Name:

INJECTION, SUSPENSION

Administration Route:

Intramuscular

Substances:

Name: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN

Strength: 40.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN

Strength: 60.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN

Strength: 40.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN

Strength: 20.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN

Strength: 20.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN

Strength: 20.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN

Strength: 20.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN

Strength: 20.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN

Strength: 30.0

Unit: ug/.5mL

Packages:

Code: 00006-4119-01

Description:

Effective Date: Dec. 10, 2014

Discontinued:

Code: 00006-4119-02

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4119-02) > .5 mL in 1 VIAL, SINGLE-DOSE (0006-4119-01)

Effective Date: Dec. 10, 2014

Discontinued: May 22, 2019

Code: 00006-4119-03

Description: 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4119-03) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4119-01)

Effective Date: Dec. 10, 2014

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Protective Agent

Minor Class:

HPV Vaccine

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC